How much funding has Cronos Group Inc. Common Share raised?

Cronos Group Inc. Common Share has raised $1.8B in total funding, most recently a Corporate Round.

Who are Cronos Group Inc. Common Share's investors?

Cronos Group Inc. Common Share's investors include Altria Ventures.

Where is Cronos Group Inc. Common Share headquartered?

Cronos Group Inc. Common Share is headquartered in Toronto, Canada.

What industry is Cronos Group Inc. Common Share in?

Cronos Group Inc. Common Share operates in Healthcare.

How many employees does Cronos Group Inc. Common Share have?

Cronos Group Inc. Common Share has 201-500 employees.

Cronos Group Inc. Common Share

IPO

Home - The Cronos Group

Public · Toronto, Canada · $1.8B raised

Healthcare

Headquarters: Toronto
Employees: 201–500
Business Model: B2B2C
Website: thecronosgroup.com

Total Funding: $1.8B
Last Round: $1.8B Corporate RoundMar 2019
Rounds: 1
Type: Public

About

Cronos Group Inc. (NASDAQ: CRON, TSX: CRON) is a global cannabis company focused on scaling consumer goods products through R&D and innovation. The company cultivates, produces, distributes, and markets cannabis products in Canada, Israel, and internationally under its portfolio of brands: Spinach®, PEACE NATURALS®, LIT™, and Lord Jones®. Founded in 2012 and incorporated in Ontario, Cronos has built a diverse international presence, with Spinach reaching the #1 market share in vapes in Canada and PEACE NATURALS as the #1 cannabis brand in Israel. The company is known for its strong balance sheet and disciplined approach to international expansion, reporting record net revenues and gross profits in 2025 and Q1 2026.

Summary

Cronos Group Inc. Common Share is a Healthcare company based in Toronto, Canada. It has raised $1.8B in total across 1 round, most recently a $1.8B Corporate Round round in Mar 2019. Investors include Altria Ventures.

LinkedIn X (Twitter)